ETFs With GlaxoSmithKline PLC (GSK) Exposure
The following ETFs maintain significant exposure to GlaxoSmithKline PLC (GSK); each of the following funds counts GSK among its top ten individual holdings. Note that percentages in the table reflect weightings at the beginning of the current month, and are subject to change.
To see a complete breakdown of any of the ETFs included in the table below, including sector, market cap, and country allocations, click on the ticker symbol.
|Ticker||ETF||ETFdb Category||Expense Ratio||Weighting|
|PPH||Market Vectors Pharmaceutical ETF||Health & Biotech Equities||0.35%||4.90%|
|ADRU||BLDRS Europe 100 ADR Index Fund||Europe Equities||0.30%||3.33%|
|ADRD||BLDRS Developed Markets 100 ADR Index||Foreign Large Cap Equities||0.30%||2.69%|
|PID||Intl Dividend Achievers||Foreign Large Cap Equities||0.54%||2.01%|
© 2015 Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.